Aksìa, through its fund Aksìa capital V, announces the sale of 100% of MIR

Milan, January 29, 2025 – Aksìa SGR S.p.A. has successfully completed the sale of MIR – Medical International Research, a leading company in the spirometry sector. The company’s shares were acquired by Quadrivio’s Silver Economy Fund, alongside a group of co-investors, marking a new chapter in the growth of MIR.

The transaction involved the sale of the stakes held by the Aksìa Capital V Fund, Overseas Industries, founder Siro Brugnoli, Giovanni Carlino and the rest of the management team. As part of the deal, Roberta Di Pinto and Adriano Mencarini, respectively the new CEO and CTO of MIR, will reinvest in the company, ensuring managerial and strategic continuity.

MIR represents the first exit of the Aksìa Capital V fund, successfully completed just four years after the investment and five years from the fund’s vintage. The transaction reflects Aksìa’s approach in supporting the growth and internationalization of its portfolio companies, guiding them through sustainable development paths and creating long-term value.